此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Effect of Breast Milk, 10% and 20% Dextrose on Pain and Physiological Variables During Heel Puncture in Infants

2026年8月22日 更新者:Ozlem Guzel Polat、Mersin University

The Effect of Oral Breast Milk and 20% Dextrose Solution Administered With Supportive Positioning Methods on Pain and Physiological Variables During Heel Puncture Blood Sampling in Preterm Infants: A Randomized Controlled Trial

Pain, defined by the International Association for the Study of Pain as a subjective, sensory, and emotional experience, differs from nociception, which is merely a neural activity. Premature newborns, whose inhibitory fibers are not yet mature due to anatomical and physiological development and who have insufficient endogenous opioid release, experience painful stimuli much more intensely. The inability of this age group to verbally express pain makes the diagnosis, assessment, and management of pain entirely dependent on healthcare professionals. Pain that is not effectively managed leads to stress and loss of comfort in the short term, while in the long term it can cause permanent neurodevelopmental problems and alter the individual's pain threshold later in life.

Premature infants, especially those in Neonatal Intensive Care Units (NICUs), are exposed to invasive procedures that cause moderate to severe pain, such as heel prick tests, much more frequently than healthy term infants. In this context, pain management is a fundamental and essential nursing responsibility for the infant's neuroprotective developmental care. The literature shows that various non-pharmacological methods, such as oral sucrose, non-nutritive sucking (NNS), facilitated flexion, and wrapping, are used to alleviate pain during interventional procedures. Although more readily available in NICUs, studies on the effectiveness of oral glucose solutions are more limited compared to sucrose.

This research, designed to address this gap in the existing literature, aims to investigate the effect of "oral breast milk, 20%, and 10% dextrose solution administered with supportive positioning methods" on pain reduction during heel prick blood sampling in premature newborns. The results of this research are expected to contribute to the development of a new, easily applicable, effective, and evidence-based nursing intervention strategy for NICUs.

研究概览

详细说明

Aim: This study aims to determine the primary effect of oral breast milk, 20% dextrose, and 10% dextrose solutions-administered alongside supportive positioning methods during routine heel lancing blood sampling (within the Neonatal Screening Program)-on pain scores in premature newborns admitted to the NICUs. Secondarily, it aims to evaluate the effects of these interventions on heart rate and oxygen saturation variables.

Hypotheses: The research hypothesizes that there is a statistically significant difference between the oral breast milk, 20% dextrose, and 10% dextrose solution groups (applied with supportive positioning) regarding pain scores (H1a), heart rate (H1b), and oxygen saturation levels (H1c) during the heel lancing procedure.

Study Design: The study will be conducted using a single-center, parallel-group, randomized controlled trial design.

Study Location: The research will take place in the Neonatal Intensive Care Unit of Mersin University Hospital.

NICUs Characteristics: The unit features a traditional open-bay design comprising two wards. It provides level 4a care and has a total incubator capacity of 27.

Work Environment and Care Approach: As a tertiary referral center, the NICUs operates on two shifts (08:00-16:00 and 16:00-08:00), with a nurse-to-infant ratio ranging from 1:1 to 1:3. The unit adopts a family-centered individualized developmental care approach. The Turkish version of the Neonatal Pain, Agitation, and Sedation Scale (N-PASS) is routinely used to evaluate and record pain scores during shift changes and interventional procedures.

Study Population: The study population will consist of premature newborns admitted to the Mersin University Hospital NICU who are scheduled for routine heel prick blood sampling.

Sample Size: The sample size was determined via a priori power analysis using G*Power 3.1.9.4. Based on the effect size (d=0.92) from Brovedani et al. (2007), a minimum of 26 infants per group is required to detect a statistically significant difference with a 5% type I error margin (α = 0.05) and 90% power (1-β = 0.90).

Attrition Allocation: To account for potential dropouts and confounding variables, the sample size was increased by 20%. Consequently, the study will include a total of 96 premature newborns, with 32 infants assigned to each of the three intervention groups.

Data Collection Tools and Forms

  • Infant Information and Observation Form: Developed by the researcher based on the literature, this 11-item form records demographic and clinical data such as gestational age, birth weight, procedure duration, heart rate, oxygen saturation, and N-PASS scores.
  • N-PASS Scale: A valid and reliable tool for the multidimensional assessment of pain, incorporating both physiological (heart rate, saturation, respiratory rate) and behavioral (crying, facial expression, muscle tone) components. To compensate for the limited behavioral responses of premature infants, gestational age-based points are added. The clinical goal is to maintain a score below 3.
  • Physiological Measurement Tools: A monitor and a compatible pulse oximeter sensor will be placed on the infant's right hand (palmar/preductal area) to measure the average heart rate and capillary oxygen saturation before, during, and after the procedure.
  • Camera: A tablet will be used to record the infant's facial expressions, behavioral responses, and monitor readings. Recording will start 3 minutes prior to the procedure and end 2 minutes after its completion.
  • Heating and Puncture Devices: A radiant heater will be used to warm the nurse's hands, monitored by an infrared thermometer. A disposable mechanical/automatic lancet specifically designed for preemies (0.85 mm depth, 1.75 mm width) will be utilized for the puncture.

Study Implementation Steps

  • Preparation: Following ethical committee and institutional approvals, informed written consent will be obtained from the parents. The Infant Information Form will be filled out 30 minutes before the procedure. To ensure standardization, a single researcher-nurse will perform the blood collections while another records the video.
  • Positioning (15 minutes prior): The infant will be swaddled in a supine facilitated flexion position (trunk flexed, limbs in midline, head and shoulders elevated 30-45°) to provide postural support (nesting).
  • Pre-procedure Intervention (2 minutes prior): 1 mL of the assigned oral solution will be slowly administered to the anterior part of the infant's tongue using a PPD syringe. Non-nutritive sucking will be initiated, and the puncture site (heel) will be warmed in the nurse's palm.
  • The Procedure: The oral solution will be administered once more immediately before the puncture. The site will be cleaned with an antiseptic, punctured, and the first drop of blood wiped away before collecting the sample on Guthrie paper. An injection bandage will then be applied.
  • Evaluation Process: Video recordings will be evaluated at four distinct time points: 2 minutes before (T0), during (T1), 1 minute after (T3), and 2 minutes after (T4) the procedure. The N-PASS scoring will be conducted independently by the nurse performing the procedure and an external certified neonatal nursing expert using the video footage.

Information regarding the duration of the procedure, the duration of the baby's crying, and heart rate and saturation before, during, and after the procedure will be obtained from camera recordings.

Analysis of Research Data: A statistical software package will be used to analyze the research data. The statistical significance level has been set at 0.05. Kolmogrow-Smirnov and Shapiro-Wilk tests will be used for normality analysis of dependent variables. Chi-square and mean comparison tests will be used to determine the similarity of groups. Appropriate parametric or non-parametric tests will be used to compare intra-group and between-group means, depending on whether the distribution is normal. In case of differences in between-group means, the appropriate effect size will be used according to the test family. Agreement and correlation analyses will be performed between N-PASS score evaluators. Additionally, post-hoc power analysis will be used to test whether the study was conducted with an adequate sample size. Effect Size: Cohen's d coefficient will be calculated to determine the strength of the difference between the groups.

研究类型

介入性

注册 (估计的)

96

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子

接受健康志愿者

不

描述

Inclusion Criteria:

  • Parental consent for the baby's participation in the study
  • Admission to Mersin University Hospital NICU between July 16, 2026 and December 30, 2026,
  • Gestational age at birth between 33 weeks and 37 weeks,
  • Postnatal age less than 7 days,
  • Heel prick blood test planned within the scope of NTP,
  • Stable clinical condition,
  • Absence of genetic or metabolic problems,
  • Developed sucking-swallowing and breathing coordination,
  • Having been fed at least 30 minutes before the procedure,
  • No experience with invasive procedures in the last 6 hours before the procedure,
  • No administration of non-opioid analgesics in the last 4 hours before the procedure,
  • No administration of opioid analgesics and sedative agents in the last 24 hours before the procedure,
  • Spontaneous respiration at 21% FiO2,
  • Absence of neurological problems (e.g., asphyxia, hypoxic ischemic encephalopathy, intraventricular hemorrhage, periventricular leukomalacia, spinal cord injury…),
  • Absence of contraindications to oral glucose/breast milk administration (e.g., necrotizing enterocolitis or suspicion thereof, feeding intolerance, tracheoesophageal fistula, absence of esophageal atresia…),
  • Absence of endocrine problems (e.g., hypoglycemia, hyperglycemia, large for gestational age, absence of a diabetic mother…),

Exclusion Criteria:

  • Parental disapproval of infant's participation in the study
  • No hospitalization at Mersin University Hospital NICUs between July 16, 2026 and December 30, 2026,
  • Gestational age at birth less than 33 weeks or greater than 37 weeks,
  • Postnatal age greater than 7 days,
  • Heel prick blood test not planned within the scope of NTP,
  • Clinical condition not stable,
  • Lack of developed sucking-swallowing and breathing coordination,
  • Having been fed within 30 minutes of the procedure,
  • Having had invasive procedures experience in the last 6 hours before the procedure,
  • Having received non-opioid analgesics in the last 4 hours before the procedure,
  • Having received opioid analgesics and sedative agents in the last 24 hours before the procedure,
  • Genetic or metabolic problem The following are contraindications:
  • Being on invasive or non-invasive mechanical ventilation support,
  • Having a neurological problem,
  • Oral glucose/breast milk administration being contraindicated,
  • Having an endocrine and metabolic problem.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:breast milk group
supportive positioning techniques during routine heel prick blood sampling and oral breastfeeding.
Administering oral breast milk in a supportive position
实验性的:10% dextrose solution group
Application of 10% dextrose solution with supportive positioning during routine heel prick blood sampling.
Application of 10% dextrose solution with supportive positioning during routine heel prick blood sampling.
实验性的:20% dextrose solution group
Application of 20% dextrose solution with supportive positioning during routine heel prick blood sampling.
Application of 20% dextrose solution with supportive positioning during routine heel prick blood sampling.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in the mean score of neonatal pain, agitation and sedation scale
大体时间:During the procedure
The Neonatal Pain, Agitation, and Sedation Scale has a maximum score of 10, a minimum score of 0, and no lower limit. It is generally interpreted that "the higher the score on the scale, the more pain the baby is in."
During the procedure

次要结果测量

结果测量
措施说明
大体时间
The effect of orally administered breast milk, 10% and 20% dextrose solutions, along with supportive positioning techniques during heel prick blood sampling in premature infants, on heart rate.
大体时间:During the procedure
The effect of orally administered breast milk, 10% and 20% dextrose solutions, along with supportive positioning techniques during heel prick blood sampling in premature infants, on heart rate.
During the procedure
The effect of supportive positioning techniques during heel prick blood sampling in premature infants, along with orally administered breast milk, 10% and 20% dextrose solutions, on respiratory rate.
大体时间:During the procedure
The effect of supportive positioning techniques during heel prick blood sampling in premature infants, along with orally administered breast milk, 10% and 20% dextrose solutions, on respiratory rate.
During the procedure

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年7月18日

初级完成 (估计的)

2026年8月15日

研究完成 (估计的)

2026年9月30日

研究注册日期

首次提交

2026年7月16日

首先提交符合 QC 标准的

2026年7月16日

首次发布 (实际的)

2026年7月21日

研究记录更新

最后更新发布 (实际的)

2026年8月25日

上次提交的符合 QC 标准的更新

2026年8月22日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅